pocketful logo
Natural Biocon (India) Ltd logo

Natural Biocon (India) Ltd

NSE: BSE: 543207

4.20

(-5.83%)

Tue, 03 Mar 2026, 00:20 pm

Natural Biocon (India) News

Natural Biocon Q3FY26 Results Show Revenue Decline

Natural Biocon (India) Limited reported zero revenue for Q3FY26 ended December 31, 2025, compared to ₹127.73 lakhs in Q3FY25, resulting in a net loss of ₹4.27 lakhs.

13 Feb 2026

co actions results

Natural Biocon Reports Mixed Q2 Results with Zero Revenue and Rs 4.37 Lakh Loss

Natural Biocon (India) Limited reported zero net sales for Q2 ended September 30, 2025, resulting in a loss of Rs 4.37 lakhs, compared to Rs 20.24 lakhs profit in the same quarter last year. The company's half-year results showed profit of Rs 9.49 lakhs with revenue of Rs 166.57 lakhs, significantly lower than Rs 29.99 lakhs profit and Rs 572.34 lakhs revenue in the previous year's corresponding period.

01 Dec 2025

earnings

Natural Biocon Reports Mixed Financial Performance in Second Quarter Results

Natural Biocon (India) Limited's Board approved unaudited financial results for the second quarter and half year ended September 30, 2025, showing a net loss after tax of Rs. 4.37 lakhs for the quarter compared to a profit of Rs. 20.24 lakhs in the previous quarter. The company's total income from operations decreased to Rs. 166.87 lakhs for the half year compared to Rs. 572.58 lakhs in the previous year, while maintaining an equity share capital of Rs. 2578.28 lakhs.

19 Nov 2025

earnings

Natural Biocon India Reports 42% Jump in Net Profit for Q1 FY2026

Natural Biocon (India) Limited reported a net profit of Rs 13.86 lakhs for the quarter ended June 30, 2025, compared to Rs 9.75 lakhs in the same period last year. Revenue from operations increased to Rs 166.57 lakhs from Rs 98.65 lakhs year-on-year. The company's total expenses rose to Rs 152.71 lakhs from Rs 88.90 lakhs in the corresponding quarter. Basic and diluted earnings per share stood at Rs 0.05. The Board of Directors approved these unaudited financial results during their meeting held on August 13, 2025. The company operates in a single business segment and is listed on BSE and Calcutta Stock Exchange.

13 Aug 2025

earnings

Biocon Receives Approval for Liraglutide Drug in India

Biocon has received approval for the generic version of Victoza, a drug containing Liraglutide, in India. This medication is used for the treatment of Type 2 diabetes.

02 Jun 2025

default

Showing 15 of 8
Rows per page:

Market Current News

Strait of Hormuz Remains Open Despite IRGC Claims

Fox News reporter cites U.S. Central Command confirming Strait of Hormuz remains operational, contradicting claims from Iran's Islamic Revolutionary Guard Corps about closure of the strategic waterway.

02 Mar 2026

global

Dow Jones Closes Lower by 48.36 Points

The Dow Jones Industrial Average unofficially closed down 48.36 points or 0.10% at 48,929.56, marking a slight decline in the trading session.

02 Mar 2026

global

S&P 500 Closes Marginally Higher at 6,883.39

The S&P 500 index posted a modest gain of 4.51 points or 0.07% in unofficial closing figures, reaching 6,883.39 as markets showed steady performance.

02 Mar 2026

global

Nasdaq Gains 0.44% to Close at 22,766.87

The Nasdaq composite index posted gains in trading, advancing 98.66 points or 0.44% to reach an unofficial closing level of 22,766.87 points.

02 Mar 2026

global

US to Launch Energy Cost Offset Program - Rubio

Secretary of State Rubio announces upcoming program to offset energy costs, with Treasury and Energy departments set to reveal oil cost mitigation steps.

02 Mar 2026

global

Showing 15 of 89244
Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800